Published in J Acquir Immune Defic Syndr on September 01, 2014
Observational research on NCDs in HIV-positive populations: conceptual and methodological considerations. J Acquir Immune Defic Syndr (2014) 0.87
Noncommunicable diseases in HIV infection in low- and middle-income countries: gastrointestinal, hepatic, and nutritional aspects. J Acquir Immune Defic Syndr (2014) 0.87
Association between Highly Active Antiretroviral Therapy and Type of Infectious Respiratory Disease and All-Cause In-Hospital Mortality in Patients with HIV/AIDS: A Case Series. PLoS One (2015) 0.81
Brief Report: A Phase 1b/Pharmacokinetic Trial of PTC299, a Novel PostTranscriptional VEGF Inhibitor, for AIDS-Related Kaposi's Sarcoma: AIDS Malignancy Consortium Trial 059. J Acquir Immune Defic Syndr (2016) 0.75
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med (1998) 53.26
1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep (1992) 22.29
Mentoring in academic medicine: a systematic review. JAMA (2006) 13.66
Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet (2012) 8.22
The evolution of the population-based cancer registry. Nat Rev Cancer (2006) 5.71
Non-communicable diseases in sub-Saharan Africa: what we know now. Int J Epidemiol (2011) 4.74
Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst (2011) 4.69
Part I: Cancer in Indigenous Africans--burden, distribution, and trends. Lancet Oncol (2008) 3.91
Challenges and opportunities in cancer control in Africa: a perspective from the African Organisation for Research and Training in Cancer. Lancet Oncol (2013) 3.12
Does mentoring matter: results from a survey of faculty mentees at a large health sciences university. Med Educ Online (2010) 2.92
Improvement of pathology in sub-Saharan Africa. Lancet Oncol (2013) 2.88
Kaposi's sarcoma in homosexual men-a report of eight cases. Lancet (1981) 2.75
Revolutionising cancer care in South Africa. Lancet Oncol (2012) 2.70
Effect of treating co-infections on HIV-1 viral load: a systematic review. Lancet Infect Dis (2010) 2.60
Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children. Pediatr Blood Cancer (2010) 2.37
Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer (2006) 2.25
Treatment of cancer in sub-Saharan Africa. Lancet Oncol (2013) 2.07
Non-communicable diseases in sub-Saharan Africa: the case for cohort studies. PLoS Med (2010) 1.88
Scale-up of HIV treatment through PEPFAR: a historic public health achievement. J Acquir Immune Defic Syndr (2012) 1.78
Cancer incidence in Nigeria: a report from population-based cancer registries. Cancer Epidemiol (2012) 1.78
The challenge of cancer control in Africa. Nat Rev Cancer (2008) 1.71
Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. MMWR Morb Mortal Wkly Rep (1986) 1.71
Clinical characteristics and outcome of children with Burkitt lymphoma in Uganda according to HIV infection. Pediatr Blood Cancer (2009) 1.69
Saving the children--improving childhood cancer treatment in developing countries. N Engl J Med (2005) 1.62
Aids and cancer in Africa: the evolving epidemic in Zimbabwe. AIDS (1999) 1.61
Why are a quarter of faculty considering leaving academic medicine? A study of their perceptions of institutional culture and intentions to leave at 26 representative U.S. medical schools. Acad Med (2012) 1.61
Developing cancer control plans in Africa: examples from five countries. Lancet Oncol (2013) 1.53
Immunosenescence and HIV. Curr Opin Immunol (2012) 1.51
The increasing burden of HIV-associated malignancies in resource-limited regions. Annu Rev Med (2011) 1.47
Ageing with HIV in South Africa. AIDS (2011) 1.37
Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in Zambia. PLoS One (2013) 1.37
Immunohistochemical and molecular subtypes of breast cancer in Nigeria. Breast Cancer Res Treat (2007) 1.35
Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991-2010. Int J Cancer (2013) 1.29
Part II: Cancer in Indigenous Africans--causes and control. Lancet Oncol (2008) 1.27
The United States President's Emergency Plan for AIDS Relief: a story of partnerships and smart investments to turn the tide of the global AIDS pandemic. J Acquir Immune Defic Syndr (2012) 1.23
Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1995) 1.21
Challenge of pediatric oncology in Africa. Semin Pediatr Surg (2012) 1.18
HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data. Infect Agent Cancer (2011) 1.16
Mentorship needs at academic institutions in resource-limited settings: a survey at Makerere University College of Health Sciences. BMC Med Educ (2011) 1.15
Pediatric malignancies, treatment outcomes and abandonment of pediatric cancer treatment in Zambia. PLoS One (2014) 1.13
Accuracy of Burkitt lymphoma diagnosis in constrained pathology settings: importance to epidemiology. Arch Pathol Lab Med (2011) 1.11
Cancer in Botswana: resources and opportunities. Lancet Oncol (2013) 1.11
Analysis of factors contributing to the low survival of cervical cancer patients undergoing radiotherapy in Kenya. PLoS One (2013) 1.11
Spectrum of HIV/AIDS related cancers in India. Cancer Causes Control (2007) 1.09
Solar thermal polymerase chain reaction for smartphone-assisted molecular diagnostics. Sci Rep (2014) 1.08
Complex care systems in developing countries: breast cancer patient navigation in Ethiopia. Cancer (2010) 1.08
Cervical cancer risk factors among HIV-infected Nigerian women. BMC Public Health (2013) 1.07
Ocular surface squamous neoplasia in patients with HIV infection in sub-Saharan Africa. Curr Opin Oncol (2010) 1.06
HIV-1 Tat promotes Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6-induced angiogenesis and tumorigenesis by regulating PI3K/PTEN/AKT/GSK-3β signaling pathway. PLoS One (2013) 1.05
The spectrum of cancers in West Africa: associations with human immunodeficiency virus. PLoS One (2012) 1.04
Association between older age and adverse outcomes on antiretroviral therapy: a cohort analysis of programme data from nine countries. AIDS (2012) 1.03
The roles of national cancer research institutions in evolving a comprehensive cancer control program in a developing country: experience from Uganda. Oncology (2009) 1.01
The globalization of tobacco use: 21 challenges for the 21st century. CA Cancer J Clin (2010) 1.00
Increasing incidence of Kaposi's sarcoma in black South Africans in KwaZulu-Natal, South Africa (1983-2006). Int J STD AIDS (2009) 0.99
Role of inflammation in HIV-1 disease progression and prognosis. Crit Rev Clin Lab Sci (2014) 0.99
The survival benefits of antiretroviral therapy in South Africa. J Infect Dis (2013) 0.98
Cancer burden among HIV-positive persons in Nigeria: preliminary findings from the Nigerian AIDS-cancer match study. Infect Agent Cancer (2014) 0.95
Building capacity for sustainable research programmes for cancer in Africa. Nat Rev Clin Oncol (2014) 0.94
Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors. J Int AIDS Soc (2010) 0.94
Implementation of cervical cancer prevention services for HIV-infected women in Zambia: measuring program effectiveness. HIV Ther (2010) 0.94
Infection with human immunodeficiency virus-1 (HIV) among children with cancer in South Africa. Pediatr Blood Cancer (2011) 0.92
Epidemic of lung cancer in patients with HIV infection. Chest (2013) 0.92
Testicular cancer: Management challenges in an African developing country. S Afr Med J (2010) 0.90
The oncology pharmacy in cancer care delivery in a resource-constrained setting in western Kenya. J Oncol Pharm Pract (2012) 0.90
Misdiagnosis of tuberculosis in patients with lymphoma. S Afr Med J (2012) 0.89
Clinicopathological review of ocular surface squamous neoplasia in Malawi. Br J Ophthalmol (2013) 0.89
African Burkitt's lymphoma: could collaboration with HIV-1 and malaria programmes reduce the high mortality rate? Lancet (2010) 0.89
Cancer in Africa: opportunities for collaborative research and training. Afr J Med Med Sci (2009) 0.88
Practicing western oncology in Shanghai, China: one group's experience. J Oncol Pract (2013) 0.86
Agreement between diagnoses of childhood lymphoma assigned in Uganda and by an international reference laboratory. Clin Epidemiol (2012) 0.85
Cancer in cohort of HIV-infected population: prevalence and clinical characteristics. J Cancer Res Clin Oncol (2010) 0.84
Aflatoxin exposure in developing countries: the critical interface of agriculture and health. Food Nutr Bull (2007) 0.84
Prevalence of undiagnosed HIV infection in patients with ocular surface squamous neoplasia in a tertiary center in Karnataka, South India. Cornea (2012) 0.84
Cancer risk in persons with HIV/AIDS in India: a review and future directions for research. Infect Agent Cancer (2009) 0.83
Massive benefits of antiretroviral therapy in Africa. J Infect Dis (2013) 0.82
Opportunistic non-Hodgkin's lymphomas among severely immunocompromised HIV-infected patients surviving for prolonged periods on antiretroviral therapy--United States. MMWR Morb Mortal Wkly Rep (1991) 0.81
Interdisciplinary tumour boards in Switzerland: quo vadis? Swiss Med Wkly (2008) 0.79
Caregiver burden among poor caregivers of patients with cancer in an urban African setting. Psychooncology (2010) 0.79
"Not a nice experience, not at all": Underprivileged women's experiences of being confronted with cervical cancer. Palliat Support Care (2014) 0.78
Recent developments for cancer care in Africa. Lancet Oncol (2012) 0.78
HIV/AIDS. Cancer genes help HIV persist, complicating cure efforts. Science (2014) 0.78
Cancer in resource-limited settings. J Acquir Immune Defic Syndr (2011) 0.77
Putting the brakes on cancer in Africa. Cancer Discov (2012) 0.76
Knowledge, attitudes and practices of AIDS associated malignancies among people living with HIV in Nigeria. Infect Agent Cancer (2012) 0.76
Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia. AIDS (2003) 4.82
Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst (2011) 4.69
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature (2012) 4.33
Rethinking prevention of HIV type 1 infection. Clin Infect Dis (2010) 4.19
Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications. J Clin Oncol (2004) 4.06
Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol (2006) 3.68
Effectiveness of a city-wide program to prevent mother-to-child HIV transmission in Lusaka, Zambia. AIDS (2005) 2.97
Comparison of two strategies for administering nevirapine to prevent perinatal HIV transmission in high-prevalence, resource-poor settings. J Acquir Immune Defic Syndr (2003) 2.97
Does douching increase risk for sexually transmitted infections? A prospective study in high-risk adolescents. Am J Obstet Gynecol (2008) 2.96
Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression. AIDS (2008) 2.91
Combination HIV prevention: significance, challenges, and opportunities. Curr HIV/AIDS Rep (2011) 2.72
Effect of treating co-infections on HIV-1 viral load: a systematic review. Lancet Infect Dis (2010) 2.60
Physician emigration from sub-Saharan Africa to the United States: analysis of the 2011 AMA physician masterfile. PLoS Med (2013) 2.47
Hepatitis C virus infection in former commercial plasma/blood donors in rural Shanxi Province, China: the China Integrated Programs for Research on AIDS. J Infect Dis (2005) 2.47
Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia. AIDS (2009) 2.42
Predictors of successful early infant diagnosis of HIV in a rural district hospital in Zambézia, Mozambique. J Acquir Immune Defic Syndr (2011) 2.39
Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst (2002) 2.38
Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children. Pediatr Blood Cancer (2010) 2.37
Co-infection with HIV and hepatitis C virus in former plasma/blood donors: challenge for patient care in rural China. AIDS (2006) 2.36
Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants? Clin Infect Dis (2005) 2.32
Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia. PLoS Med (2011) 2.28
Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus. J Natl Cancer Inst (2002) 2.23
Early clinical and immune response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine. AIDS (2007) 2.19
A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol (2007) 2.17
Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infect Dis (2008) 2.13
AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and/or biology? Blood (2010) 2.10
Treatment of cancer in sub-Saharan Africa. Lancet Oncol (2013) 2.07
A phase I, open-label study of siltuximab, an anti-IL-6 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma, multiple myeloma, or Castleman disease. Clin Cancer Res (2013) 2.02
Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma. Clin Cancer Res (2008) 1.94
Factors associated with delayed initiation of HIV medical care among infected persons attending a southern HIV/AIDS clinic. South Med J (2006) 1.88
Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy. AIDS Res Hum Retroviruses (2008) 1.84
Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034. J Clin Oncol (2009) 1.84
Training programmes in global health. BMJ (2010) 1.83
Paradoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection. Clin Infect Dis (2011) 1.82
An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programs. Am J Epidemiol (2010) 1.81
Nurturing the global workforce in clinical research: the National Institutes of Health Fogarty International Clinical Scholars and Fellows Program. Am J Trop Med Hyg (2011) 1.81
Cannabis smoking and risk of lung cancer in men: a pooled analysis of three studies in Maghreb. J Thorac Oncol (2008) 1.74
Predictors of adherence to antiretroviral therapy in rural Zambia. J Acquir Immune Defic Syndr (2008) 1.73
Vaginal douching: evidence for risks or benefits to women's health. Epidemiol Rev (2002) 1.71
High prevalence of HIV and syphilis in a remote native community of the Peruvian Amazon. Am J Trop Med Hyg (2007) 1.70
Clinical correlates of herpes simplex virus viremia among hospitalized adults. Clin Infect Dis (2009) 1.69
Improving retention in the early infant diagnosis of HIV program in rural Mozambique by better service integration. J Acquir Immune Defic Syndr (2011) 1.68
Breast cancer risk among women who start smoking as teenagers. Cancer Epidemiol Biomarkers Prev (2005) 1.66
Prevalence and correlates of HIV and syphilis infections among men who have sex with men in seven provinces in China with historically low HIV prevalence. J Acquir Immune Defic Syndr (2010) 1.65
Sociocultural and epidemiological aspects of HIV/AIDS in Mozambique. BMC Int Health Hum Rights (2010) 1.64
Predictors of survival after a diagnosis of non-Hodgkin lymphoma in a resource-limited setting: a retrospective study on the impact of HIV infection and its treatment. J Acquir Immune Defic Syndr (2011) 1.63
Monitoring and evaluation of programmes to prevent mother to child transmission of HIV in Africa. BMJ (2007) 1.63
Child survival in relation to mother's HIV infection and survival: evidence from a Ugandan cohort study. AIDS (2003) 1.62
Educational programs to enhance medical expertise in tropical diseases: the Gorgas Course experience 1996-2001. Am J Trop Med Hyg (2002) 1.60
Expansion of HIV/AIDS in China: lessons from Yunnan Province. Soc Sci Med (2006) 1.58
The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients. Biol Blood Marrow Transplant (2009) 1.56
Effect of nevirapine toxicity on choice of perinatal HIV prevention strategies. Am J Public Health (2002) 1.56
Risk factors for syphilis and prevalence of HIV, hepatitis B and C among men who have sex with men in Beijing, China: implications for HIV prevention. AIDS Behav (2008) 1.55
Use of traditional medicine among pregnant women in Lusaka, Zambia. J Altern Complement Med (2007) 1.55
HIV voluntary counseling and testing among injection drug users in south China: a study of a non-government organization based program. AIDS Behav (2007) 1.55
Temozolomide plus thalidomide in patients with advanced melanoma: results of a dose-finding trial. J Clin Oncol (2002) 1.54
Time for oncologists to opt in for routine opt-out HIV testing? JAMA (2010) 1.53
Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman's disease. J Clin Oncol (2010) 1.53
Primary esophageal carcinoma in the era of highly active antiretroviral therapy. Arch Intern Med (2010) 1.52
Delayed access to HIV diagnosis and care: Special concerns for the Southern United States. AIDS Care (2006) 1.52
Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy. AIDS (2011) 1.52
A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic. J Acquir Immune Defic Syndr (2005) 1.51
Cervical cancer prevention in low- and middle-income countries: feasible, affordable, essential. Cancer Prev Res (Phila) (2011) 1.50
Lung cancer risk and workplace exposure to environmental tobacco smoke. Am J Public Health (2007) 1.47
CpG methylation as a tool to characterize cell-free Kaposi sarcoma herpesvirus DNA. J Infect Dis (2012) 1.44
HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease. Clin Infect Dis (2008) 1.42
Prevalence of HIV infection and predictors for syphilis infection among female sex workers in southern China. Southeast Asian J Trop Med Public Health (2009) 1.42
Partner notification for sexually transmitted infections in developing countries: a systematic review. BMC Public Health (2010) 1.42
More on HIV-associated Kaposi's sarcoma. N Engl J Med (2008) 1.38
Treatment of intestinal helminths does not reduce plasma concentrations of HIV-1 RNA in coinfected Zambian adults. J Infect Dis (2005) 1.37
Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in Zambia. PLoS One (2013) 1.37
Prevention and treatment of cancer-related infections. J Natl Compr Canc Netw (2008) 1.36
Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited. Int J Cancer (2008) 1.35
Estimates of HIV prevalence in a highly endemic area of China: Dehong Prefecture, Yunnan Province. Int J Epidemiol (2008) 1.35
Prevention and treatment of cancer-related infections. J Natl Compr Canc Netw (2012) 1.35
Clinical and ultrasonographic features of abdominal tuberculosis in HIV positive adults in Zambia. BMC Infect Dis (2009) 1.35
Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response. AIDS (2008) 1.33
Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers. Ann Epidemiol (2008) 1.33
Training programs within global networks: lessons learned in the Fogarty International Clinical Research Scholars and Fellows Program. Am J Trop Med Hyg (2013) 1.33
Recruiting trainees for a global health research workforce: the National Institutes of Health Fogarty International Clinical Research Scholars Program selection process. Am J Trop Med Hyg (2013) 1.33
The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal. Virus Res (2009) 1.31
CC chemokine receptor 5 genotype and susceptibility to transmission of human immunodeficiency virus type 1 in women. J Infect Dis (2003) 1.29
Cervical cancer screening by visual inspection in Côte d'Ivoire, operational and clinical aspects according to HIV status. BMC Public Health (2012) 1.29
Do targeted HIV programs improve overall care for pregnant women?: Antenatal syphilis management in Zambia before and after implementation of prevention of mother-to-child HIV transmission programs. J Acquir Immune Defic Syndr (2008) 1.29
Comparison of visual inspection with acetic acid and cervical cytology to detect high-grade cervical neoplasia among HIV-infected women in India. Int J Cancer (2011) 1.29
Barriers to antiretroviral therapy adherence in rural Mozambique. BMC Public Health (2011) 1.28
Willingness to be circumcised for preventing HIV among Chinese men who have sex with men. AIDS Patient Care STDS (2009) 1.28
Elevated risk for squamous cell carcinoma of the conjunctiva among adults with AIDS in the United States. Int J Cancer (2008) 1.27
Meeting the challenge of hematologic malignancies in sub-Saharan Africa. Blood (2012) 1.26
Factors associated with HIV testing among HIV-positive and HIV-negative high-risk adolescents: the REACH Study. Reaching for Excellence in Adolescent Care and Health. Pediatrics (2002) 1.26
Host genetic profiles predict virological and immunological control of HIV-1 infection in adolescents. AIDS (2002) 1.24
Estimation of HIV-1 incidence among five focal populations in Dehong, Yunnan: a hard hit area along a major drug trafficking route. BMC Public Health (2010) 1.23
Trimodal age-specific incidence patterns for Burkitt lymphoma in the United States, 1973-2005. Int J Cancer (2010) 1.23
Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma. Mol Ther (2008) 1.22
Breast cancer risk and the combined effect of environmental estrogens. Cancer Causes Control (2004) 1.22
HIV, Hepatitis B, and Hepatitis C in Zambia. J Glob Infect Dis (2011) 1.22